ArticleClinical case reports2026
A Rare Case of P-Null Phenotype Identified During Preoperative Screening.
Article in Clinical case reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
A 46-year-old woman scheduled for an elective total abdominal hysterectomy was incidentally found to have a rare P-null (p) phenotype during routine preoperative testing. Although her ABO/Rh type was A positive, the antibody screen demonstrated strong pan-reactivity with all panel cells, while the autocontrol was negative, indicating an alloantibody. This prompted referral to a reference immunohematology laboratory, where the pan-agglutinating antibody was ultimately identified as specific anti-P1Pk, consistent with the patient's rare P-null phenotype. Consequently, the patient was flagged as requiring future transfusions with P-null, ABO/Rh-compatible red blood cells. Surgery proceeded without the need for transfusion, but identification of this rare phenotype has substantial implications for long-term care, particularly given the known association of anti-PP1Pk with severe hemolytic transfusion reactions and recurrent pregnancy loss. This case highlights the importance of comprehensive pretransfusion testing, early collaboration with specialized laboratories, meticulous documentation, and proactive transfusion planning, particularly in regions where such phenotypes may be underrecognized.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.